Engineering microglia exosome for delivering microRNA-124-3p offers therapeutic potential for Alzheimer's disease, suggesting a new combination approach.
Currently, single target therapy and difficulty in brain drug delivery gravely impeded the treatment of Alzheimer's disease (AD). The promising development of MicroRNA-124-3p (miR-124-3p) serves the possibility for multiple therapeutic...
No takes yet. Share an insight, caveat, or question.
Ke et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: